In 2011, another study examined NAC's effect
on women with polycystic ovary syndrome, this time comparing it to the common diabetes drug metformin.
Not exact matches
For example
women who suffer
with PCOS,
polycystic ovary syndrome, in some cases have a delay
on the state of lactation so they may struggle to make enough milk in the first week or so after giving birth.
A leading expert
on reproductive health says young
women with Polycystic Ovary Syndrome (PCOS) have a startlingly higher risk of developing type 2 diabetes, even if young and not overweight.
The PCOS Awareness Symposium featured some of the world's leading experts
on PCOS and covered the pathophysiology and psychology of
polycystic ovary syndrome; ways to reduce risks for infertility, diabetes, cardiovascular disease, cancer, and other PCOS complications; nutrition, hair removal and medical treatment options for
women and girls
with PCOS.
Impact of a mindfulness stress management program
on stress, anxiety, depression and quality of life in
women with polycystic ovary syndrome: a randomized controlled trial.
Increased thrombin generation in
women with polycystic ovary syndrome: A pilot study
on the effect of metformin and oral contraceptives.
A Single Arm Pilot Study of Effects of Berberine
on the Menstrual Pattern, Ovulation Rate, Hormonal and Metabolic Profiles in Anovulatory Chinese
Women with Polycystic Ovary Syndrome.
The effects of coenzyme Q10 supplementation
on glucose metabolism and lipid profiles in
women with polycystic ovary syndrome: a randomized, double - blind, placebo - controlled trial.
The effect of omega - 3 supplementation
on androgen profile and menstrual status in
women with polycystic ovary syndrome: A randomized clinical trial.
Visit any
polycystic ovary syndrome (PCOS) chat
on social media and you're sure to come across recommendations from other
women with the
syndrome plugging a gluten - free diet.
A comparison between the effects of metformin and N - acetyl cysteine (NAC)
on some metabolic and endocrine characteristics of
women with polycystic ovary syndrome.
Stefanaki C, Bacopoulou F, Livadas S, Kandaraki A, Karachalios A, Chrousos GP, Diamanti - Kandarakis E. Impact of a mindfulness stress management program
on stress, anxiety, depression and quality of life in
women with polycystic ovary syndrome: a randomized controlled trial.
Khani B, Mehrabian F, Khalesi E, Eshraghi A. Effect of soy phytoestrogen
on metabolic and hormonal disturbance of
women with polycystic ovary syndrome.
Testing should be considered for all individuals who are overweight or obese (BMI 25 or greater) plus the additional risks: first degree relative
with diabetes mellitus or
Polycystic Ovarian Disease, history of gestational diabetes, thyroid disorder, HDL level < 35 mg / dl and / or Triglyceride level > 250 mg / dl, hypertensive, sedentary, impaired glucose tolerance (IGT) or impaired fasting glucose (IFG) on previous testing, women who delivered macrosomic baby (e.g. weighing > 9 lbs), and other clinical conditions such as acanthosis nigricans, severe obesity, polycystic ovary syndrome, dys
Polycystic Ovarian Disease, history of gestational diabetes, thyroid disorder, HDL level < 35 mg / dl and / or Triglyceride level > 250 mg / dl, hypertensive, sedentary, impaired glucose tolerance (IGT) or impaired fasting glucose (IFG)
on previous testing,
women who delivered macrosomic baby (e.g. weighing > 9 lbs), and other clinical conditions such as acanthosis nigricans, severe obesity,
polycystic ovary syndrome, dys
polycystic ovary syndrome, dyslipidemia.
Savic - Radojevic A, Bozic Antic I, Coric V, Bjekic - Macut J, Radic T, Zarkovic M, Djukic T, Pljesa - Ercegovac M, Panidis D, Katsikis I, Simic T, Macut D. Effect of hyperglycemia and hyperinsulinemia
on glutathione peroxidase activity in non-obese
women with polycystic ovary syndrome.